Whitefort Capital Management, LP
Follow13F filer, CIK 1884931, NEW YORK, NY
Whitefort Capital Management, LP reported $391,173,545 across 20 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-17. Its ten largest share positions make up 88.98% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001013594-26-000254
- Period
- 2025-12-31
- Reported value
- $391M
- Holdings
- 20
- Top 10 weight
- 88.98%
- New
- 4
- Sold out
- 2
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| SOCnew | +1,910,793 | $17.2M |
| QUREnew | +459,000 | $11M |
| BALYadded | +578,129 | $9.55M |
| TDAYadded | +1,189,427 | $6.13M |
| SGRYadded | +229,000 | $3.54M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ROIVreduced | -1,412,000 | -$30.6M |
| LQDAreduced | -449,409 | -$15.5M |
| GNWreduced | -1,161,659 | -$10.5M |
| IWMexited | -33,000 | -$7.98M |
| OPKreduced | -646,660 | -$815K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2025
Share positions as resolved from 13F-HR 0001013594-26-000254, largest first. % of portfolio is the value over $330,471,972, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ABUSARBUTUS BIOPHARMA CORP | 13,343,228 | $64.2M | 19.42% | 0 | Timeline | ||
| ROIVROIVANT SCIENCES LTD | 2,120,000 | $46M | 13.92% | -1,412,000 | Timeline | ||
| BALYBALLYS CORPORATION | 1,921,372 | $31.7M | 9.6% | +578,129 | Timeline | ||
| OABIOMNIAB INC | 14,223,658 | $26.3M | 7.96% | 0 | Timeline | ||
| JOYYJOYY INC | 404,944 | $26.2M | 7.94% | 0 | Timeline | ||
| TDAYUSA TODAY CO INC | 4,774,833 | $24.6M | 7.44% | +1,189,427 | Timeline | ||
| GNWGENWORTH FINL INC | 2,540,301 | $22.9M | 6.94% | -1,161,659 | Timeline | ||
| CDZICADIZ INC | 3,986,822 | $22.4M | 6.77% | 0 | Timeline | ||
| SOCSABLE OFFSHORE CORP | 1,910,793 | $17.2M | 5.22% | new | Timeline | ||
| QUREUNIQURE NV | 459,000 | $11M | 3.32% | new | Timeline | ||
| SGRYSURGERY PARTNERS INC | 600,000 | $9.27M | 2.81% | +229,000 | Timeline | ||
| LQDALIQUIDIA CORPORATION | 158,000 | $5.45M | 1.65% | -449,409 | Timeline | ||
| OPKOPKO HEALTH INC | 4,253,340 | $5.36M | 1.62% | -646,660 | Timeline | ||
| VATEINNOVATE CORP | 743,000 | $3.36M | 1.02% | 0 | Timeline | ||
| KGKESTREL GROUP LTD | 160,916 | $1.65M | 0.5% | 0 | Timeline | ||
| NNAVWNEXTNAV INC | 47,264 | $338K | 0.1% | 0 | Timeline |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
Principal amounts
Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| OPKO HEALTH INCOPKO HEALTH INC NOTE 3.750% 1/1 | principal | 9,350,000 | $12.5M | 0 |
Sold out in Q4 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
How Q4 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001013594-26-000254 | base | 2026-02-17 | acceptance time not in the bulk data set |